Deputy Chief Physician, Associate Researcher, and Doctoral Supervisor of the Department of Hepatobiliary and Pancreatic Surgery I, Peking University Cancer Hospital. Long dedicated to comprehensive treatment of hepatobiliary malignancies, performing over 300 hepatobiliary tumor surgeries and managing over 1,000 medication-based cases annually. Selected as a Beijing High-Level Innovative and Entrepreneurial Talent, among the first batch of Physician-Scientists by the Beijing Municipal Health Commission, a Qingmiao Talent of the Beijing Hospital Authority, a Young Talent Support Program recipient of the Beijing Association for Science and Technology, and a Third-Peking University Outstanding Young Physician. Currently serves as a member of the Youth Working Group of the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association, a member of the Integrated Rehabilitation Committee for Pancreatic Tumors of the Chinese Anti-Cancer Association, a member of the Chinese Young and Middle-Aged Liver Cancer Research Collaborative Group, Secretary of the Hepatobiliary and Pancreatic Professional Committee of the Beijing Anti-Cancer Association, Secretary-General of the Liver Metastasis Professional Committee of the Beijing Cancer Prevention and Treatment Society, Editorial Board Member of the Chinese edition of LIVER CANCER and the Electronic Journal of Liver Cancer, and manages the official WeChat public platform "Peking University Cancer Hepatobiliary and Pancreatic Surgery I". Published over 20 original articles as first/corresponding author in journals such as Nature Communications, Cell Reports Medicine, Nucleic Acids Research, and International Journal of Surgery. Leads multiple research projects funded by the National Natural Science Foundation of China, the Key R&D Program of the Ministry of Science and Technology, and Peking University Clinical Medicine + X.